Percutaneous Treatment of Saphenous Vein Graft Disease: The Ongoing Challenge

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1370-1372

  Baim, Donald S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ATHEROSCLEROSIS; CATHETER; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY PERFORATION; DEVICE; DISEASE COURSE; EDITORIAL; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REDUCTION; RISK FACTOR; SAPHENOUS VEIN GRAFT; SURGICAL TECHNIQUE; THORAX PAIN; VEIN DISEASE; VEIN GRAFT; VEIN GRAFT DISEASE;

EID: 0142043905     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01039-8     Document Type: Editorial

References (16)

1. Morrison DS, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience for post-CABG patients. J Am Coll Cardiol 2002;40:1951-4.
2. Hong MK, Mehran R, Mintz GS, et al. Are we making progress with percutaneous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-4.
3. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001;38:659-65.
4. Kuntz RE, Baim DS, Cohen DJ, et al., for the VeGAS 2 Investigators. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (The Vein Graft Angiojet Study [VeGAS 2]). Am J Cardiol 2002;89:326-30.
5. Stone GW, Cox DA, Low R, et al. Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesion in native coronary arteries and saphenous vein grafts: results from the multicenter X-sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) study. Cathet Cardiovasc Interv 2003;58:419-27.
6. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-5.
7. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994;89:2514-8.
8. Ellis SG, Linkoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998;32:1619-23.
9. Baim DS, Wahr D, George B, et al., on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
10. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108: 548-53.
11. Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4-6 year) outcome after Palmaz-Schatz stenting - paucity of late stent-related problems. J Am Coll Cardiol 1996;28: 820-6.
12. Ellis SG, Brener SJ, De Luca S, et al. Late myocardial ischemic events after saphenous vein graft intervention - importance of initially "non-significant" vein graft lesions. Am J Cardiol 1997;79:1460-4.
13. Waksman R, White RL, Chan RC, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002;346:1194-9.
14. Baldus S, Koster R, Reimers J, Meinertz T, Hamm CW. Membrane-covered stents: a new treatment strategy for saphenous vein graft lesions. Cathet Cardiovasc Interv 2001;53:1-4.
15. Schächinger V, Hamm CW, Munzel T, et al. A randomized trial of polytetrafluoroethylene-membrane covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003;42:1360-9.
16. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation 2003;108:37-42.